Application of diagnostic criteria for optic neuritis - Authors' reply
- PMID: 37059502
- DOI: 10.1016/S1474-4422(23)00110-2
Application of diagnostic criteria for optic neuritis - Authors' reply
Conflict of interest statement
AP declares grant support for remyelination trials in multiple sclerosis to the Amsterdam University Medicam Centre, Department of Neurology, MS Centre (for the RESTORE trial), and University College London (for the RECOVER trial); funding for a trial from Fight for Sight (nimodipine in optic neuritis trial); royalties or licenses from Up-to-Date (Wolters Kluver) on a book chapter; speaker fees from the Heidelberg Academy; participation on advisory boards for SC Zeiss Optical Coherence Tomography Angiorgaphy Angi-Network and the SC Novartis Optical Coherence Tomography in Multiple Sclerosis study; leadership roles for a governing board for International Multiple Sclerosis Visual System Consortium (until December, 2022) and Chairman of European Reference Network for rare Eye Diseases Neuro-ophthalmology (until October, 2020); is a board member of National Dutch Neuro-ophthalmology Association; received equipment from Optical Coherence Tomography Angiorgaphy and Zeiss (Plex Elite); and provided medical writing support to Novartis. YL declares no competing interests.
Comment on
-
Diagnosis and classification of optic neuritis.Lancet Neurol. 2022 Dec;21(12):1120-1134. doi: 10.1016/S1474-4422(22)00200-9. Epub 2022 Sep 27. Lancet Neurol. 2022. PMID: 36179757 Review.
-
Application of diagnostic criteria for optic neuritis.Lancet Neurol. 2023 May;22(5):375. doi: 10.1016/S1474-4422(23)00111-4. Lancet Neurol. 2023. PMID: 37059500 No abstract available.
-
Application of diagnostic criteria for optic neuritis.Lancet Neurol. 2023 May;22(5):375-376. doi: 10.1016/S1474-4422(23)00112-6. Lancet Neurol. 2023. PMID: 37059501 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical